US$ 20.05
combination therapy with glp-1 receptor agonist and sglt2 inhibitor Full article: therapy: a complementary approach to the treatment of type 2 diabetes GLP-1 receptor agonists and next-generation
Description
L.StaffordL

Zoungas, H

[DOI] [PubMed] [Google Scholar] 49.Bell G.I., Santerre R.F., Mullenbach G.T

Mounjaro is injected once weekly
